CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $1.00 thousand for the 3-month period ending 2014-03-29, per its 10-Q filed 2014-04-30.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2014-04-30
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2014-03-29 was $1.00K, a 97.37% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-09-28 was $177.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-06-29 was $261.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2013-03-30 was $38.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month |
|---|---|---|---|
| 2014-03-29 | $1.00K 10-Q · filed 2014-04-30 | ||
| 2013-09-28 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $438.00K derived: sum of 2 quarters · filed 2013-10-30 | $476.00K 10-Q · filed 2013-10-30 |
| 2013-06-29 | $261.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $299.00K 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $38.00K 10-Q · filed 2014-04-30 | ||
| 2012-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $0.00 10-Q · filed 2013-10-30 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $0.00 10-Q · filed 2013-07-31 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |